Amedisys Inc

155.35-6.18-3.83%Vol 551.09K1Y Perf -30.70%
Sep 24th, 2021 16:00 DELAYED
BID154.00 ASK168.37
Open159.25 Previous Close161.53
Pre-Market- After-Market155.35
 - -  - -%
Target Price
231.20 
Analyst Rating
Moderate Buy 1.75
Potential %
48.83 
Finscreener Ranking
★★+     48.31
Insiders Trans % 3/6/12 mo.
-100/-100/-97 
Value Ranking
★★+     48.38
Insiders Value % 3/6/12 mo.
-100/-100/-90 
Growth Ranking
★★★★+     64.62
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-90 
Income Ranking
 —    -
Price Range Ratio 52W %
0.49 
Earnings Rating
Strong Sell
Market Cap5.07B 
Earnings Date
27th Oct 2021
Alpha0.02 Standard Deviation0.11
Beta0.50 

Today's Price Range

154.52159.52

52W Range

154.52325.12

5 Year PE Ratio Range

-283.30162.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-9.22%
1 Month
-13.20%
3 Months
-37.79%
6 Months
-41.98%
1 Year
-30.70%
3 Years
25.81%
5 Years
218.86%
10 Years
1 026.54%

TickerPriceChg.Chg.%
AMED155.35-6.1800-3.83
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Financial StrengthValueIndustryS&P 500US Markets
0.80
0.90
0.22
0.32
34.30
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
44.90
14.10
17.40
7.80
11.42
RevenueValueIndustryS&P 500US Markets
2.20B
67.30
9.41
9.23
Earnings HistoryEstimateReportedSurprise %
Q02 20211.641.693.05
Q01 20211.431.547.69
Q04 20201.451.492.76
Q03 20201.272.2476.38
Q02 20200.791.3469.62
Q01 20200.971.058.25
Q04 20190.930.941.08
Q03 20190.901.1527.78
Earnings Per EndEstimateRevision %Trend
9/2021 QR1.35-27.42Negative
12/2021 QR1.45-26.02Negative
12/2021 FY6.08-12.89Negative
12/2022 FY6.50-12.87Negative
Next Report Date27th Oct 2021
Estimated EPS Next Report1.35
Estimates Count7
EPS Growth Next 5 Years %11.00
Volume Overview
Volume551.09K
Shares Outstanding32.63M
Shares Float28.16M
Trades Count9.37K
Dollar Volume78.94M
Avg. Volume245.92K
Avg. Weekly Volume310.00K
Avg. Monthly Volume336.94K
Avg. Quarterly Volume335.80K

Amedisys Inc (NASDAQ: AMED) stock closed at 155.35 per share at the end of the most recent trading day (a -3.83% change compared to the prior day closing price) with a volume of 551.09K shares and market capitalization of 5.07B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 21000 people. Amedisys Inc CEO is Paul B. Kusserow.

The one-year performance of Amedisys Inc stock is -30.7%, while year-to-date (YTD) performance is -47.04%. AMED stock has a five-year performance of 218.86%. Its 52-week range is between 154.52 and 325.12, which gives AMED stock a 52-week price range ratio of 0.49%

Amedisys Inc currently has a PE ratio of 23.00, a price-to-book (PB) ratio of 6.39, a price-to-sale (PS) ratio of 2.49, a price to cashflow ratio of 21.00, a PEG ratio of 2.32, a ROA of 14.82%, a ROC of 21.45% and a ROE of 30.23%. The company’s profit margin is 11.42%, its EBITDA margin is 17.40%, and its revenue ttm is $2.20 Billion , which makes it $67.30 revenue per share.

Of the last four earnings reports from Amedisys Inc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.35 for the next earnings report. Amedisys Inc’s next earnings report date is 27th Oct 2021.

The consensus rating of Wall Street analysts for Amedisys Inc is Moderate Buy (1.75), with a target price of $231.2, which is +48.83% compared to the current price. The earnings rating for Amedisys Inc stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amedisys Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amedisys Inc has a Sell technical analysis rating based on Technical Indicators (ADX : 20.37, ATR14 : 6.12, CCI20 : -167.53, Chaikin Money Flow : -0.18, MACD : -10.15, Money Flow Index : 21.79, ROC : -16.06, RSI : 23.35, STOCH (14,3) : 2.52, STOCH RSI : 0.00, UO : 30.59, Williams %R : -97.48), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amedisys Inc in the last 12-months were: Bruce D. Perkins (Buy at a value of $259 376), Christopher Gerard (Option Excercise at a value of $0), Christopher Gerard (Sold 9 350 shares of value $2 461 683 ), David Kemmerly (Option Excercise at a value of $0), David Kemmerly (Sold 1 003 shares of value $275 810 ), Denise M. Bohnert (Option Excercise at a value of $24 380), Denise M. Bohnert (Sold 1 176 shares of value $356 921 ), Michael North (Option Excercise at a value of $0), Paul B. Kusserow (Option Excercise at a value of $0), Scott G. Ginn (Option Excercise at a value of $213 330), Scott G. Ginn (Sold 7 800 shares of value $2 027 074 ), Sharon Brunecz (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (58.33 %)
7 (58.33 %)
8 (66.67 %)
Moderate Buy
1 (8.33 %)
1 (8.33 %)
1 (8.33 %)
Hold
4 (33.33 %)
4 (33.33 %)
3 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.75
Moderate Buy
1.75
Moderate Buy
1.58

Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patient's homes throughout the United States. The Hospice segment operates many centers designed to provide comfort and support for terminally ill patients. The Personal Care Segment provides individuals with assistance in the daily living activities. A majority of the company's revenue is derived from the Home Health segment. Additionally, the Hospice segment accounts for a substantial amount of revenue, while the Personal Care segment makes up for the small remaining revenue.

CEO: Paul B. Kusserow

Telephone: +1 225 292-2031

Address: 3854 American Way, Baton Rouge 70816, LA, US

Number of employees: 21 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

55%45%

Bearish Bullish

60%40%

TipRanks News for AMED

Thu, 19 Aug 2021 12:05 GMT Analysts Offer Insights on Healthcare Companies: Amedisys (AMED), Lineage Cell Therapeutics (LCTX) and Moderna (MRNA)

- TipRanks. All rights reserved.

Fri, 06 Aug 2021 12:34 GMT Amedisys (AMED) Receives a Buy from Jefferies

- TipRanks. All rights reserved.

News

Stocktwits